Are you Dr. Hardy?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2280 Hemby Ln
Greenville, NC 27834Phone+1 252-744-9400Fax+1 252-744-9401
Summary
- Dr. John Hardy, MD is a board certified neurologist in Greenville, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with ECU Health Medical Center and is a Neurologist at ECU Physicians Neurology.
Education & Training
- Wake Forest University Baptist Medical CenterResidency, Neurology, 1974 - 1978
- Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 1973 - 1974
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1973
Certifications & Licensure
- NC State Medical License 1973 - 2018
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Publications & Presentations
PubMed
- 231 citationsIncreased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s diseaseAmanda Heslegrave, Wendy E. Heywood, Ross W. Paterson, Nadia K. Magdalinou, Johan Svensson
Molecular Neurodegeneration. 2016-01-12 - 577 citationsCommon genetic variants influence human subcortical brain structures.Derrek P. Hibar, Jason L. Stein, Miguel E. Rentería, Alejandro Arias-Vasquez, Sylvane Desrivières
Nature. 2015-04-09 - 155 citationsNovel genetic loci underlying human intracranial volume identified through genome-wide associationHieab H.H. Adams, Derrek P. Hibar, Vincent Chouraki, Jason L. Stein, Paul A. Nyquist
Nature Neuroscience. 2016-12-01
Press Mentions
- ‘Patients Deserve Better Treatments for Dementia’: NHS Hopes for New Alzheimer’s DrugNovember 26th, 2022
- Breakthrough Alzheimer’s Drug Could Be in UK Use in a Year but Only for MinorityNovember 23rd, 2022
- Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data SetsFebruary 1st, 2021
- Join now to see all